Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy's Disease 2025-10-23 11:24
Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain 2025-10-23 04:00
ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors 2025-10-22 14:00
ACROBiosystems and Partners Conclude OrganoAsia 2025 2025-10-22 11:03
ACROBiosystems and Partners Conclude OrganoAsia 2025 2025-10-22 11:01
NSG Bio Launches NSG BioSuites at Geneo - A New Product, Largest Site, and Fourth Location in Singapore 2025-10-21 08:00
LabConnect Featured in Season Finale of Emmy-Nominated Series Tomorrow's World Today 2025-10-21 01:11
Benchling Partners with Anthropic to Build a Bridge Between Science and AI 2025-10-21 00:00
The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC 2025-10-20 17:06
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions 2025-10-20 14:00
Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO 2025-10-20 13:59
Alphamab Oncology Presented Multiple Clinical Data on Biparatopic HER2-targeting ADC JSKN003 at ESMO Congress 2025 2025-10-20 13:15
Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM 2025-10-20 10:36
Antengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability 2025-10-20 09:00
Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity 2025-10-20 08:10
Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting 2025-10-19 15:00
SCG announces presentation of clinical results of SCG142 in patients with HPV-related carcinoma at ESMO 2025 2025-10-18 13:00
Kelun-Biotech's Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC 2025-10-17 20:22
Chula Launches Newborn Genome Sequencing Project for Early Detection and Prevention of Genetic Diseases 2025-10-17 16:00
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences 2025-10-17 15:21
1 4 5 6 7 8 264